Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes

SHOTA NOHIRA, SHUNICHIRO KURAMITSU, MASASUKE OHNO, MITSUGU FUJITA, KIMIHIRO YAMASHITA, TORU NAGASAKA, SHOICHI HAIMOTO, NORIAKI SAKAKURA, HIROKAZU MATSUSHITA and RYUTA SAITO
Anticancer Research August 2024, 44 (8) 3615-3621; DOI: https://doi.org/10.21873/anticanres.17184
SHOTA NOHIRA
1Department of Neurosurgery, Nagoya University Faculty of Medicine, Nagoya, Japan;
2Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUNICHIRO KURAMITSU
2Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan;
3Department of Neurosurgery, Nagoya Medical Center, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASASUKE OHNO
4Department of Neurosurgery, Aichi Cancer Center, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tennjikunezumi{at}gmail.com
MITSUGU FUJITA
5Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka-Sayama, Japan;
6Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mfujita47{at}gmail.com
KIMIHIRO YAMASHITA
6Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU NAGASAKA
6Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan;
7Association of Medical Artificial Intelligence Curation (AMAIC), Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHOICHI HAIMOTO
4Department of Neurosurgery, Aichi Cancer Center, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORIAKI SAKAKURA
8Department of Thoracic Surgery, Aichi Cancer Center, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKAZU MATSUSHITA
2Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYUTA SAITO
1Department of Neurosurgery, Nagoya University Faculty of Medicine, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Lung cancer-derived brain metastases (BMs) consist of immature tertiary lymphoid structures (TLSs). (A and B) Representative pathological images of TLSs in primary lung cancer and BMs. The sections were stained with CD4 (red), CD20 (brown), and Bcl-6 (green). (A) A TLS in a primary lung cancer. Magnification: 10×, scale bar: 100 μm. (B) A TLS in a BM tissue. Magnification: 20×, scale bar: 50 μm. (C and D) Comparison of the densities of TLSs (C) and tumor-infiltrating lymphocytes (TILs; D) in the primary lung cancers (n=5) and the BMs (n=17). p-Values were determined using the Mann–Whitney U-test. *p<0.05; ***p<0.001.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Tertiary lymphoid structure (TLS) density, but not tumor-infiltrating lymphocyte (TIL) density, in brain metastases (BMs) correlates with patients’ survival after surgical resection. Kaplan–Meier plots displaying postoperative overall survival (OS) of the patients with BMs stratified into high- (n=8) and low-density groups (n=9) based on TLS (A) and TIL (B). p-Values were determined by log-rank test. *p<0.05; N.S.: Not significant.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Tertiary lymphoid structure (TLS) density in brain metastases (BMs) is a prognostic factor in patients with lung cancer-derived BM independent of Graded prognostic assessment (GPA) index. The cohorts were classified into two groups based on the GPA index for the correlations between the GPA index, an established prognostic index of BMs, and postoperative overall survival (OS) (A). the TLS density of BMs (B), and the TIL density of BMs (C). p-Values were determined using the Mann–Whitney U-test. *p<0.05; N.S.: Not significant.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
17 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes
SHOTA NOHIRA, SHUNICHIRO KURAMITSU, MASASUKE OHNO, MITSUGU FUJITA, KIMIHIRO YAMASHITA, TORU NAGASAKA, SHOICHI HAIMOTO, NORIAKI SAKAKURA, HIROKAZU MATSUSHITA, RYUTA SAITO
Anticancer Research Aug 2024, 44 (8) 3615-3621; DOI: 10.21873/anticanres.17184

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes
SHOTA NOHIRA, SHUNICHIRO KURAMITSU, MASASUKE OHNO, MITSUGU FUJITA, KIMIHIRO YAMASHITA, TORU NAGASAKA, SHOICHI HAIMOTO, NORIAKI SAKAKURA, HIROKAZU MATSUSHITA, RYUTA SAITO
Anticancer Research Aug 2024, 44 (8) 3615-3621; DOI: 10.21873/anticanres.17184
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Immature Peritumoral Tertiary Lymphoid Structures Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After NAC
  • Hallmarks of adaptive immunity in a metastatic clear cell renal cell carcinoma (ccRCC) long-term elite survivor
  • Prognostic Value of Tertiary Lymphoid Structures in Epithelial Ovarian Carcinoma
  • Potential Role of Tumor-derived MIF in B-Cell Antigen Presentation in Lung Adenocarcinoma: Single-cell and TCGA Analyses
  • Characterization of Tumor Immune Microenvironment in Meningiomas: Correlation of Tumor-infiltrating Lymphocyte Aggregates With Tumor Grade
  • Identification and characterization of tertiary lymphoid structures in brain metastases
  • Google Scholar

More in this TOC Section

  • Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer
  • Effect of Increased Image Matrix on Lung Nodule Volumetry in Chest CT: A Phantom Study
  • Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer
Show more Clinical Studies

Keywords

  • Tertiary lymphoid structures
  • brain metastases
  • Lung cancer
  • tumor immune microenvironment (TIME)
  • prognostic biomarkers
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire